{"id":"W1584179619","doi":"10.1002/cncr.29240","title":"Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic‐ or accelerated‐phase chronic myeloid leukemia: Results with 24 months of follow‐up","year":2015,"lang":"en","type":"article","venue":"Cancer","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institutes of Health; Teva Pharmaceutical Industries","keywords":"Medicine; Internal medicine; Gastroenterology; Neutropenia; Myeloid leukemia; Confidence interval; Adverse effect; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049782,0.0008772108,0.001823575,0.0006246403,0.0003718587,0.000885183,0.0005007276,0.000559823,0.001240646],"category_scores_gemma":[0.002661828,0.0001911508,0.003284737,0.0005606998,0.0003359134,0.0003648581,0.0005537347,0.0007343192,0.0003282414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000953947,"about_ca_system_score_gemma":0.0007328703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009479293,"about_ca_topic_score_gemma":0.001086278,"domain_scores_codex":[0.9983151,0.0006182687,0.000162305,0.0003069934,0.0003479998,0.0002493324],"domain_scores_gemma":[0.9968451,0.0007795639,0.0008733899,0.0003454747,0.0006753512,0.0004810581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3788506,0.004269154,0.4850138,0.0006367069,0.009721016,0.0004944889,0.0002657624,0.004983927,0.03139712,0.0001510481,0.002441385,0.08177511],"study_design_scores_gemma":[0.01371132,0.09878037,0.8650691,0.00003915851,0.004957254,0.0007721957,0.00009117198,0.002153991,0.009380286,0.00009557248,0.004898302,0.00005128131],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939669,0.001272887,0.0006667458,0.00007309465,0.0000163625,0.000547243,0.002514658,0.00003653622,0.0009054629],"genre_scores_gemma":[0.9903841,0.0001845568,0.0007971665,0.0001144869,0.0000305542,0.000344279,0.00733934,0.00001203783,0.0007933486],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0049782,"threshold_uncertainty_score":0.02632755,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03353811094204888,"score_gpt":0.2990981108762727,"score_spread":0.2655599999342238,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}